WS #13308
Holding: newest synthesis is 100d 9h old
KKR acquires Integer for $127/share (51.8% premium) and Supernus merges with Indivior in all-stock deal, creating a $2.2B CNS company.
Healthcare M&A: KKR-Integer and Supernus-Indivior
KKR acquires Integer for $127/share (51.8% premium) and Supernus merges with Indivior in all-stock deal, creating a $2.2B CNS company.